Application 022058
- Type
- NDA
- Sponsor
- ENDO PHARM
Related Records
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUPPRELIN LA | HISTRELIN ACETATE | IMPLANT;SUBCUTANEOUS | 50MG | Yes | Yes |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67979-002 | SUPPRELIN | histrelin acetate | Endo Pharmaceuticals Inc. | NDA | Current |
| 67979-002 | SUPPRELIN | histrelin acetate | Endo Pharmaceuticals Solutions Inc. | NDA | Current |
| 67979-002 | SUPPRELIN | histrelin acetate | Endo Pharmaceuticals Inc. | NDA | Current |
| 67979-002 | SUPPRELIN | histrelin acetate | Endo Pharmaceuticals Inc. | NDA | Current |
| 67979-002 | SUPPRELIN | histrelin acetate | Endo Pharmaceuticals Inc. | NDA | Current |
Documents
| Document | Submission type | Date |
|---|---|---|
| 83462 | SUPPL | 2025-09-25 |
| 83461 | SUPPL | 2025-09-25 |
| 83425 | SUPPL | 2025-09-24 |
| 70825 | SUPPL | 2022-04-27 |
| 70824 | SUPPL | 2022-04-27 |
| 70810 | SUPPL | 2022-04-26 |
| 60825 | SUPPL | 2019-11-13 |
| 60823 | SUPPL | 2019-11-12 |
| 60822 | SUPPL | 2019-11-12 |
| 48493 | SUPPL | 2017-05-23 |
| 48492 | SUPPL | 2017-05-23 |
| 48474 | SUPPL | 2017-05-22 |
| 48473 | SUPPL | 2017-05-22 |
| 48472 | SUPPL | 2017-05-22 |
| 48471 | SUPPL | 2017-05-19 |
| 38160 | SUPPL | 2016-07-13 |
| 38161 | SUPPL | 2013-04-09 |
| 6790 | SUPPL | 2013-04-03 |
| 16860 | SUPPL | 2012-04-06 |
| 6789 | SUPPL | 2012-04-06 |
| 16859 | SUPPL | 2011-11-18 |
| 29169 | SUPPL | 2011-11-02 |
| 24238 | ORIG | 2008-12-02 |
| 21922 | ORIG | 2008-12-02 |
| 38159 | SUPPL | 2008-07-09 |
| 29168 | SUPPL | 2008-07-08 |
| 29167 | SUPPL | 2007-11-26 |
| 6788 | ORIG | 2007-05-09 |
| 38158 | ORIG | 2007-05-07 |